Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 223

    Pharma sector: Cabinet Approval for India-Uzbekistan MoU on cooperation

    Pharma sector: Cabinet Approval for India-Uzbekistan MoU on cooperation

    Medical Dialogues Bureau27 Sept 2018 9:00 AM IST
    The MoU will explore the possibilities for the production of medicines, including active pharmaceutical ingredients (APIs) in different therapeutic...
    Asia Healthcare in talks to acquire Nova IVI Fertility

    Asia Healthcare in talks to acquire Nova IVI Fertility

    Medical Dialogues Bureau26 Sept 2018 5:55 PM IST
    New Delhi: Asia Healthcare Holdings (AHH), an operating and investment platform founded by TPG Growth, the global middle market and growth equity...
    Veneeth Purushotaman joined to Aster DM Healthcare as the Group CIO

    Veneeth Purushotaman joined to Aster DM Healthcare as the Group CIO

    Medical Dialogues Bureau26 Sept 2018 3:55 PM IST
    Purushotaman will be responsible for creating and driving the global IT strategy of the company and consolidating its technology landscape across...
    Boston Scientific introduces LithoVue Empower-kidney stone reterival device

    Boston Scientific introduces LithoVue Empower-kidney stone reterival device

    Medical Dialogues Bureau26 Sept 2018 9:48 AM IST
    The LithoVue Empower Device was developed in direct response to a need to improve procedural bottlenecks during kidney stone removal...
    Boosting profitability: Novartis to cut 2,200 jobs in Switzerland

    Boosting profitability: Novartis to cut 2,200 jobs in Switzerland

    Medical Dialogues Bureau26 Sept 2018 9:30 AM IST
    With 450 new positions being created for the production of cell and gene therapies, Swiss positions will be cut by about 1,750 net jobs.ZURICH:...
    Gilead to launch low-cost generic versions of its hepatitis drugs

    Gilead to launch low-cost generic versions of its hepatitis drugs

    Medical Dialogues Bureau26 Sept 2018 9:00 AM IST
    Gilead said the low-cost variants of the drugs will be available at a list price of $24,000 for the most common course of therapy from January.New...
    Cipla received USFDA approval for Albendazole

    Cipla received USFDA approval for Albendazole

    Medical Dialogues Bureau25 Sept 2018 11:19 AM IST
    Albendazole is an anti-worm medication drug. It prevents newly hatched insect larvae (worms) from growing or multiplying in our body. Mumbai: Cipla...
    With new blood test, Roche dives deeper into personal cancer care

    With new blood test, Roche dives deeper into personal cancer care

    Medical Dialogues Bureau25 Sept 2018 9:42 AM IST
    Cancer is a disease of the genome and genomic profiling of every patient's tumour at the start of their treatment journey will provide transformative...
    Bayer Subside Monsanto India appoints Cherukuri Ravishankar as new MD

    Bayer Subside Monsanto India appoints Cherukuri Ravishankar as new MD

    Medical Dialogues Bureau25 Sept 2018 9:00 AM IST
    New Delhi: Seed firm Monsanto India, a subsidiary of Bayer group, has recently announced the appointment of Cherukuri Ravishankar as the Managing...
    Japan provides medical equipment worth Rs 1 billion

    Japan provides medical equipment worth Rs 1 billion

    Medical Dialogues Bureau25 Sept 2018 9:00 AM IST
    JICA had provided support for construction of physical infrastructure and medical equipment to TUTH in 1983 for the first time and in 1992 for the...
    Gufic Biosciences board approves amalgamation with Gufic Lifesciences

    Gufic Biosciences board approves amalgamation with Gufic Lifesciences

    Medical Dialogues Bureau24 Sept 2018 4:43 PM IST
    New Delhi: Gufic Bioscience has recently announced that board has approved the scheme of amalgamation of Gufic Lifesciences with the company, in a...
    AMD Drug: British Doctors Win; Novartis, Bayer, Roche Lose

    AMD Drug: British Doctors Win; Novartis, Bayer, Roche Lose

    Medical Dialogues Bureau24 Sept 2018 2:08 PM IST
    ZURICH: Drug giants Novartis, Bayer and Roche have recently lost a bid to stop British doctors from recommending a cheaper drug option for people with...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok